The University of Oxford says it will continue its COVID-19 vaccine trial in Brazil, pursuing the death of a volunteer.
The Brazilian health authority stated on Wednesday a volunteer within the clinical trial of the potential shot – which has been licenced to pharmaceutic giant AstraZeneca – had passed away.
But the university stated an independent review had revealed simply no safety concerns.
“Following careful assessment of this case within Brazil, there have been no concerns regarding safety of the clinical trial as well as the independent review in addition to the Brazilian limiter have recommended that the trial need to continue, ” a spokesman mentioned.
Sky News provides approached AstraZeneca for comment.